An estimated 1.2 million people worldwide newly acquired HIV in 2025, highlighting a dangerous plateau in the global fight against AIDS despite decades of scientific and medical advances.
According to updated figures from the World Health Organization (WHO) and UNAIDS released alongside the 26th International AIDS Conference in Rio de Janeiro, the world is falling behind on key milestones needed to end the epidemic as a public health threat by 2030.
While annual new infections and AIDS-related deaths have reached their lowest points in over 30 years, global health leaders warn that the current trajectory is extraordinarily fragile. Without immediate international intervention and funding restoration, the progress achieved over the past two decades risks total reversal.
Fragile Gains and Stark Numbers
The latest global data reflects both historic achievements and alarming vulnerabilities. Since peaking in 1994 at 3.5 million, annual new HIV infections have dropped by 65%, including a 42% reduction since 2010. AIDS-related mortality has similarly fallen, with approximately 570,000 people dying from HIV-related causes in 2025 down 60% among women and girls and 55% among men and boys since 2010.
At the end of 2025, an estimated 41.0 million people globally were living with HIV, with 32.1 million actively accessing life-saving antiretroviral therapy (ART). That brings global progress close to the "95-95-95" targets: 88% of people living with HIV knew their status, 89% of those diagnosed were receiving treatment, and 95% on treatment achieved viral suppression.
However, overall progress conceals severe regional disparities. New HIV acquisitions actually rose in three global regions and across 21 individual countries in 2025. Furthermore, roughly 9 million people living with HIV remain without treatment entirely, and nearly half of all children living with the virus lack access to pediatric antiretroviral care.
Sharp Decline in International Funding
The primary driver behind the slowing momentum is a steep collapse in international financial assistance. Overseas Development Assistance (ODA) plummeted by 23% in 2025, the sharpest one-year decline on record, severely hitting global health initiatives.
International funding dedicated specifically to HIV programs dropped by more than $1.5 billion in a single year, falling from $8.8 billion in 2024 to $7.3 billion in 2025. This 18% reduction has brought donor funding to its lowest point in nearly two decades, forcing community-led organizations and preventative services to downsize or shut down operations entirely.
Low-income and high-burden nations particularly in Sub-Saharan Africa, home to 64% of all people living with HIV have been hit hardest.
Many of these countries rely on international aid for more than 90% of their national HIV response budgets. Health officials warn that without rapid mobilization of domestic and bilateral resources, prevention pipelines and diagnostic distribution centers could face widespread failure.
Innovation Hindered by Inequitable Access
The funding crisis comes at a moment when medical science is offering unprecedented preventive tools. Long-acting pre-exposure prophylaxis (PrEP), such as twice-yearly injectable lenacapavir and monthly preventative medications, provides near-vaccine-level protection against acquiring HIV.
However, high costs and restrictive patent licensing prevent these breakthrough medications from reaching the populations that need them most. While global procurement initiatives aim to roll out injectable PrEP to 3 million people by 2028, public health experts estimate that at least 20 million people require immediate access to antiretroviral-based prevention to effectively halt transmission chains.
UNAIDS Executive Director Winnie Byanyima emphasized that technological advancement alone cannot solve the crisis without equitable distribution: "Innovation without access is not innovation, it is injustice. The test of success is not whether medicines exist, it is whether the people who need them can get them, and at an affordable price."
The Road Ahead to 2030
Health organizations warn that unless the global community closes the funding shortfall and addresses legislative and social barriers facing vulnerable groups, more than 3 million additional people could contract HIV by 2030.
Seven countries including Benin, Eswatini, Kenya, Lesotho, Nepal, Rwanda, and Zimbabwe have demonstrated that ending the epidemic is achievable by cutting new infections by nearly 80% since 2010 through sustained investment and community outreach. Replicating this success globally will require urgent debt restructuring for low-income nations, renewed donor commitments, and unhindered access to generic next-generation prevention therapies.